These studies can be connected in such a way that IL-27 promotes Tr1 cells early after BMT and can decrease GVHD independent of Tregs; yet in later stages IL-27 inhibits iTregs and Th2 cells and promotes Th1 differentiation; this ambiguous pattern is very similar to that seen in models of autoimmunity. Here, IL27 is linked to graft versus host disease.